TY  - JOUR
AU  - Salem, Mohamed E
AU  - Yin, Jun
AU  - Weinberg, Benjamin A
AU  - Renfro, Lindsay A
AU  - Pederson, Levi D
AU  - Maughan, Timothy S
AU  - Adams, Richard A
AU  - Van Cutsem, Eric
AU  - Falcone, Alfredo
AU  - Tebbutt, Niall C
AU  - Seymour, Matthew T
AU  - Diaz-Rubio, Eduardo
AU  - Aranda, Enrique
AU  - Bokemeyer, Carsten
AU  - Heinemann, Volker
AU  - Wasan, Harpreet
AU  - de Gramont, Aimery
AU  - Grothey, Axel
AU  - Shi, Qian
AU  - Sargent, Daniel J
AU  - Marshall, John L
PY  - 2018
DO  - 10.1016/j.ejca.2018.08.020
UR  - http://hdl.handle.net/10668/13010
T2  - European journal of cancer (Oxford, England : 1990)
AB  - Patients with left-sided colon tumours have better survival and respond differently to biologics compared with patients with right-sided tumours. Left-sided colon tumours and rectal cancers are often grouped together. Herein, we examined the...
LA  - en
PB  - Elsevier
KW  - Bevacizumab
KW  - Cetuximab
KW  - Left-sided colon cancer
KW  - Outcomes
KW  - Rectal cancer
KW  - Colonic neoplasms
KW  - Female
KW  - Gene pool
KW  - Humans
KW  - Male
KW  - Middle aged
KW  - Rectal neoplasms
TI  - Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database.
TY  - Research article
VL  - 103
ER  -